Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

SML3086

Sigma-Aldrich

Diclofenac

≥98% (HPLC), powder, nonsteroidal anti-inflammatory drug

Synonym(s):

2-(2,6-dichloranilino) phenylacetic acid, 2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C14H11Cl2NO2
CAS Number:
15307-86-5
Molecular Weight:
296.15
MDL number:
MFCD00056694
UNSPSC Code:
12352200
NACRES:
NA.77

product name

Diclofenac, ≥98% (HPLC)

Quality Level

100

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

ClC1=CC=CC(Cl)=C1NC2=CC=CC=C2CC(O)=O

InChI

1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)

InChI key

DCOPUUMXTXDBNB-UHFFFAOYSA-N

Biochem/physiol Actions

Diclofenac is an orally available, potent and selective nonsteroidal anti-inflammatory drug (NSAID). Diclofenac is used to treat pain and inflammatory diseases. It inhibits both cycloxygenase-1 (COX-1) and cycloxygenase-2 (COX-2).

Signal Word

Danger

Hazard Statements

H301,H361d,H372,H411

Hazard Classifications

Acute Tox. 3 Oral - Aquatic Chronic 2 - Repr. 2 - STOT RE 1 Oral

Target Organs

Gastrointestinal tract

Storage Class Code

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

SML3086-100MG:
SML3086-VAR:
SML3086-BULK:
SML3086-500MG:

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tomohiro Yoshida et al.
Bioorganic & medicinal chemistry, 20(19), 5705-5719 (2012-09-11)
Dipeptidyl peptidase IV (DPP-4) inhibition is suitable mechanism for once daily oral dosing regimen because of its low risk of hypoglycemia. We explored linked bicyclic heteroarylpiperazines substituted at the γ-position of the proline structure in the course of the investigation

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service